Clinical Trials in China / NCT06791499
Recruiting
Observational
AI-Agent for Automated Diagnosis and Predicting Using EHR and Multimodal Data
NCT06791499 · tracked via the Priya Life Science China tracker
Condition(s) studied
AI Agent
Study summary
The goal of this clinical study is to evaluate the effectiveness of an AI agent in diagnosing and predicting diseases using electronic health records (EHR) and multimodal imaging data. The AI agent leverages advanced machine learning algorithms to process and analyze diverse health data sources, aiming to assist healthcare providers in making more accurate diagnoses and predictions.
Eligibility
Inclusion Criteria:
1. Participants must have comprehensive electronic health records (EHR) available, including demographic information, medical history, and laboratory results.
2. Participants must have available multimodal imaging data (e.g., X-rays, CT scans, MRIs, ultrasounds) relevant to their health condition.
3. Participants must have a confirmed diagnosis of one or more diseases or health conditions based on clinical records or imaging data.
4. Patients must provide consent for the use of their historical health data for research purposes.
Exclusion Criteria:
1. Participants with ambiguous or unverifiable diagnoses that cannot be accurately categorized.
2. Duplicate or redundant patient data (e.g., repeated records of the same patient without clear differentiation).
Primary outcome measure(s)
- Area Under the Curve (AUC) — 1 year
AUC of the ROC curve, used to quantify diagnostic accuracy. No unit (a ratio or percentage, typically expressed as a number between 0 and 1). - F1 Score — 1 year
The F1 score is the harmonic mean of precision and sensitivity (recall). It is a good measure of the model's ability to identify both true positives and minimize false positives, especially in cases where the classes are imbalanced (e.g., when the number of healthy cases is much higher than disease cases). The F1 score ranges from 0 to 1, with 1 indicating perfect precision and recall.
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| Nanfang Hospital | Guangzhou | Guangdong | Recruiting |
| Sun Yat-Sen Memorial Hospital | Guangzhou | Guangdong | Recruiting |
| Sun Yat-sen University Cancer Hospital | Guangzhou | Guangdong | Recruiting |
| West China Hospital | Chengdu | Sichuan | Recruiting |
| First Affiliated Hospital of Wenzhou Medical University | Wenzhou | Zhejiang | Recruiting |
| Second Affiliated Hospital of Wenzhou Medical University | Wenzhou | Zhejiang | Recruiting |
More The Eye Hospital of Wenzhou Medical University trials in China
Other trials for the same condition
cRCT of AI Agent in Clinital Resoning Training
Enrolling by invitation
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06791499 on ClinicalTrials.gov ↗ ← All trials in China